What Is The Current and Historic Market Size Analysis Of The Custom Antibody Market?
The custom antibody market has seen considerable growth due to a variety of factors.
• The market size for custom antibodies has exponentially increased over the recent times. The market value is predicted to surge from $0.42 billion in 2024 to $0.47 billion in 2025, indicating a compound annual growth rate (CAGR) of 13.6%.
Numerous factors have contributed to this continued growth, including an escalated demand for custom antibodies, a rise in the adoption of precision medicine, a higher rate of chronic diseases and cancer, increased research and development activities, along with a growth in the number of clinical trials.
What are the Market Size and Expected Growth Rates for the Custom Antibody Market?
The custom antibody market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the custom antibody market is anticipated to experience a swift expansion. It is forecasted to reach $0.78 billion by 2029, with a compound annual growth rate (CAGR) of 13.3%.
The expansion during the forecast period can be attributed to factors such as increasing acceptance of targeted immunotherapy, escalating investments in biopharmaceuticals, rising instances of neurodegenerative disorders, growing demand for in vitro diagnostics (IVD) applications, and rising health care expenses. The period is also projected to see significant trends such as personalized medicine, technological innovations in antibody engineering, progress in biotechnology and genetic engineering, extended therapeutic applications, and advancements in antibody purification technology.
Which Key Drivers Are Propelling The Custom Antibody Market's Growth?
The surge in demand for personalized medicine is anticipated to drive the expansion of the custom antibody market in the future. This medical approach customizes treatment and prevention methods based on an individual's genetic profile, lifestyle, and environmental factors. This rise in demand for personalized medicine is due to progress in genomics, a higher access to therapies based on biomarkers, and an increasing consumer preference for bespoke treatment options that bolster effectiveness and lessen negative impacts. Personal medicine is made possible by custom antibody, which provides unique and customized immune reagents that boost the detection of diseases, therapeutic targeting, and identification of biomarkers for personalized treatment methods. For example, the Personalized Medicine Coalition, a not-for-profit organization based in the US, reported that in 2023, the Food and Drug Administration (FDA) greenlighted 16 new bespoke treatments for patients with rare diseases, marking an increase from 6 in 2022. Thus, the surging demand for personalized medicine is fueling the expansion of the custom antibody market.
What Are The Key Segments Within The Global Custom Antibody Market?
The custom antibody market covered in this report is segmented –
1) By Type: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Other Types
2) By Service: Antibody Development, Antibody Production And Purification, Antibody Fragmentation And Labeling
3) By Source: Mice, Rabbit, Other Sources
4) By Application: Oncology, Infectious Diseases, Neurology, Stem Cells, Immunology, Cardiovascular Diseases, Other Applications
5) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organization, Hospitals And Clinics
Subsegments:
1) By Monoclonal Antibodies: Murine Monoclonal Antibodies, Chimeric Monoclonal Antibodies, Humanized Monoclonal Antibodies, Fully Human Monoclonal Antibodies
2) By Polyclonal Antibodies: Rabbit Polyclonal Antibodies, Goat Polyclonal Antibodies, Sheep Polyclonal Antibodies, Other Animal-Derived Polyclonal Antibodies
3) By Recombinant Antibodies: Single-Chain Variable Fragment (scFv), Nanobodies, Bispecific Antibodies, Antibody Fragments
4) By Other Types: Aptamers, Nanobodies (Camelid Antibodies), Hybridomas
Pre-Book The Custom Antibody Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Custom Antibody Market?
Leading firms in the custom antibody market are concentrating on incorporating cutting-edge technology such as artificial intelligence, in an effort to boost antibody discovery, hone specificity, and fast-track development procedures. Tools such as artificial intelligence augment custom antibody productions by improving antigen selection, forecasting antibody-antigen binding, and facilitating candidate screening through machine learning, resulting in quicker and more cost-efficient biopharmaceutical study. For example, Archon Biosciences Inc., an American biotech company, secured $20 million in funding in October 2024 to create computationally-designed antibody cages which allow the tailoring of existing antibodies for therapeutic use. The company's unique technology constructs antibodies into cage structures, enabling changes to their properties without affecting their intrinsic structures. This breakthrough aims to heighten antibody affinity for therapeutic targets while minimizing off-target interactions, thereby ramping up both efficacy and safety.
Who Are the Key Players In The Custom Antibody Market?
Major companies operating in the custom antibody market are:
• Merck & Co. Inc.
• AbbVie Inc.
• Thermo Fisher Scientific Inc.
• Agilent Technologies Inc.
• Lonza Group AG
• Bio-Rad Laboratories Inc.
• Bio-Techne Corporation
• GenScript Biotech Corporation
• BioLegend Inc.
• Abcam plc
• Cusabio Biotech Co. Ltd.
• OriGene Technologies Inc.
• Cell Signaling Technology Inc.
• Abgent Inc.
• ProSci Incorporated
• Santa Cruz Biotechnology Inc.
• Rockland Immunochemicals Inc.
• Creative Biolabs Inc.
• Novus Biologicals LLC
• Creative Diagnostics Inc.
• Biorbyt Ltd.
• BIOTEM SAS
• Capra Biosciences Inc.
• Pacific Immunology Inc.
• ProteoGenix SAS
What Are The Regional Insights Into The Custom Antibody Market?
North America was the largest region in the custom antibody market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the custom antibody market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
